Anpario plc (AIM:ANP)

Market Cap	84.44M
Revenue (ttm)	38.20M
Net Income (ttm)	4.11M
Shares Out	20.60M
EPS (ttm)	0.24
PE Ratio	16.79
Forward PE	13.40
Dividend	0.11 (2.74%)
Ex-Dividend Date	Jul 10, 2025

Volume	1,080
Average Volume	23,674
Open	413.75
Previous Close	410.00
Day's Range	413.75 - 419.80
52-Week Range	266.00 - 488.55
Beta	0.68
RSI	52.90
Earnings Date	Sep 10, 2025

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 157
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.